Efficacy and Safety of Flexible Versus Fixed Dosing Intervals of Insulin Glargine 300 U/mL in People with Type 2 Diabetes

Background: Insulin glargine 300 U/mL (Gla-300) has a more constant and prolonged action profile than insulin glargine 100 U/mL and in clinical studies is associated with similar glycemic control but less hypoglycemia. Whether its effects are altered by variability of injection time was examined in...

Descripción completa

Detalles Bibliográficos
Autores principales: Riddle, Matthew C., Bolli, Geremia B., Home, Philip D., Bergenstal, Richard M., Ziemen, Monika, Muehlen-Bartmer, Isabel, Wardecki, Marek, Vinet, Laetitia, Jeandidier, Nathalie, Yki-Järvinen, Hannele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc. 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4827283/
https://www.ncbi.nlm.nih.gov/pubmed/26840338
http://dx.doi.org/10.1089/dia.2015.0290

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4827283/
https://www.ncbi.nlm.nih.gov/pubmed/26840338
http://dx.doi.org/10.1089/dia.2015.0290

Ejemplares similares